返回 
加入收藏
1例肺血栓栓塞症伴多种合并症乳腺癌患者的抗凝治疗分析与药学监护
x
请在关注微信后，向客服人员索取文件
| 篇名： | 1例肺血栓栓塞症伴多种合并症乳腺癌患者的抗凝治疗分析与药学监护 |
| TITLE： | Anticoagulation therapy analysis and pharmaceutical care for a breast cancer patient with pulmonary thromboem-bolism accompanied by multiple comorbidities |
| 摘要： | 目的 为肺血栓栓塞症（PTE）伴多种合并症乳腺癌患者的抗凝治疗和药学监护提供参考。方法临床药师参与1例PTE合并继发于系统性红斑狼疮的可疑抗磷脂综合征伴血小板重度减少的乳腺癌患者的诊疗过程，并提供制订个体化抗凝方案、监测患者出血情况等药学监护。针对患者出现的PTE，临床药师建议停用所有乳腺癌治疗药物；针对初始抗凝方案，临床药师在明确血小板重度减少并非抗凝治疗的绝对禁忌证后，建议予磺达肝癸钠注射液抗凝治疗；针对长期抗凝方案和疗程，临床药师建议优选华法林，推荐疗程至少3～6个月，并根据12周后的抗磷脂抗体谱复查结果结合肿瘤治疗方案决定是否进行无限期抗凝治疗。结果医师采纳临床药师建议。经治疗后，患者血丝痰及气促消失，血小板恢复正常，准予带药出院。结论临床药师以“抗凝-出血”为切入点，通过分析乳腺癌治疗相关药物与PTE的因果关系、充分评估患者的出血和血栓复发风险、监测患者出血症状和体征及凝血指标等药学服务，为患者制定了个体化用药方案，保障了患者用药的安全有效。 |
| ABSTRACT： | OBJECTIVE To provide a reference for anticoagulant therapy and pharmaceutical care of the breast cancer patient with pulmonary thromboembolism （PTE） accompanied by multiple comorbidities. METHODS Clinical pharmacists participated in the diagnosis and treatment of a breast cancer patient with PTE accompanied by severe thrombocytopenia and suspected antiphospholipid syndrome secondary to systemic lupus erythematosus， and provided personalized pharmaceutical care as developing individualized anticoagulation plans and monitoring patient bleeding. For the occurrence of PTE， the clinical pharmacist recommended stopping all breast cancer drugs. The clinical pharmacists also cleared that severe thrombocytopenia was not the absolute contraindication for anticoagulant treatment and suggested fondaparinux sodium as the initial anticoagulation regimen. Further， warfarin was recommended as the long-term anticoagulation regimen with a recommended treatment course of at least 3-6 months by the clinical pharmacists. Whether to continue indefinite anticoagulation therapy was based on the results of the antiphospholipid antibodies after 12 weeks combined with the tumor treatment regimen. RESULTS The physicians adopted the advice of the clinical pharmacists. After treatment， the patient’s blood phlegm and anhelation disappeared and the platelets returned to normal. The patient was allowed to be discharged with medication. CONCLUSIONS Taking the “anticoagulation-bleeding” as the starting point， the clinical pharmacists develop individualized medication plans for patients so as to ensure the safety and effectiveness of medication in the patient by providing pharmaceutical care， such as analyzing the causal relationship between breast cancer treatment-related drugs and PTE， assessing the risk of bleeding and thrombus recurrence， and monitoring patients’ bleeding symptoms and signs and coagulation indicators. |
| 期刊： | 2025年第36卷第02期 |
| 作者： | 霍萌；程齐俭；林佳媛 |
| AUTHORS： | HUO Meng，CHENG Qijian，LIN Jiayuan |
| 关键字： | 肺血栓栓塞症；血小板重度减少；抗磷脂综合征；抗凝治疗；临床药师；药学监护 |
| KEYWORDS： | pulmonary thromboembolism； severe thrombocytopenia； antiphospholipid syndrome； anticoagulation； clinical |
| 阅读数： | 6 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
